A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of Pumosetrag in Patients With Gastroesophageal Reflux Disease (GERD)

NCT01161602 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Gastroesophageal Reflux Disease

Interventions

DRUG: Pumosetrag
DRUG: Pumosetrag
OTHER: Placebo
DRUG: Pumosetrag

Sponsor

Edusa Pharmaceuticals, Inc.